Literature DB >> 8308293

Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival.

M Ide1, D Weiler, H Kita, G J Gleich.   

Abstract

To study human eosinophils, their efficient purification from peripheral blood is crucial. Although a number of purification procedures, including discontinuous Percoll and metrizamide density gradient centrifugation, have been used, it has been difficult to isolate eosinophils from normal donors with consistently high yields and purities. Recently, a new isolation technique called magnetic cell separation system (MACS) was reported. To evaluate this procedure, we isolated eosinophils from human peripheral blood using either MACS or the standard discontinuous Percoll density methods, and compared cellular viability, morphology, and response to degranulation stimuli. MACS gave a higher yield of eosinophils than Percoll density centrifugation; for example, 6.6 +/- 1.1 x 10(6) eosinophils were isolated from 20 ml of blood by MACS compared to 6.4 +/- 2.4 x 10(6) from 120 ml by Percoll density gradient. Further, the purity of eosinophils isolated by MACS was 97.1 +/- 0.5% (X +/- SEM) compared to 77.8 +/- 2.9% with Percoll. As part of the MACS protocol, erythrocytes are lysed with either 155 mM ammonium chloride or hypotonic lysis. With 155 mM ammonium chloride treatment, the eosinophils showed a striking reduction in cytokine mediated survival due to interleukin (IL)-3, IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), marked morphologic abnormalities and a reduced degranulation response. With hypotonic lysis, no differences were observed in survival and morphology between eosinophils purified by MACS and Percoll methods; the degranulation responses to stimuli were essentially the same between the two methods. Taken together, these observations suggest that the exposure of eosinophils to 155 mM ammonium chloride results in cellular damage. Therefore, MACS with hypotonic lysis is a useful technique to isolate eosinophils for biological study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8308293     DOI: 10.1016/0022-1759(94)90054-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

1.  Isolation of human eosinophils.

Authors:  K G Lim; P F Weller
Journal:  Curr Protoc Immunol       Date:  2001-05

2.  Cytokine production of neutrophils is limited to interleukin-8.

Authors:  J Altstaedt; H Kirchner; L Rink
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

3.  Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry.

Authors:  Kimberly D Dyer; Katia E Garcia-Crespo; Kristin E Killoran; Helene F Rosenberg
Journal:  J Immunol Methods       Date:  2011-04-30       Impact factor: 2.303

4.  Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP.

Authors:  Takehito Kobayashi; Hideaki Kouzaki; Hirohito Kita
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

5.  Eosinophil purification from peripheral blood.

Authors:  Praveen Akuthota; Kelsey Capron; Peter F Weller
Journal:  Methods Mol Biol       Date:  2014

6.  Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.

Authors:  A Tachibana; M Kato; H Kimura; T Fujiu; M Suzuki; A Morikawa
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

7.  Beta2-integrin-mediated adhesion and intracellular Ca2+ release in human eosinophils.

Authors:  Jennifer L Bankers-Fulbright; Kathleen R Bartemes; Gail M Kephart; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-03-17       Impact factor: 1.843

8.  Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b.

Authors:  Juhan Yoon; Jens U Ponikau; Christopher B Lawrence; Hirohito Kita
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

9.  Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation.

Authors:  M Kaneko; M C Swanson; G J Gleich; H Kita
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  ATP drives eosinophil effector responses through P2 purinergic receptors.

Authors:  Takehito Kobayashi; Tomoyuki Soma; Toru Noguchi; Kazuyuki Nakagome; Hidetomo Nakamoto; Hirohito Kita; Makoto Nagata
Journal:  Allergol Int       Date:  2015-07-10       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.